An in vivo platform to select and evolve aggregation-resistant proteins
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An in vivo platform to select and evolve aggregation-resistant proteins
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-14
DOI
10.1038/s41467-020-15667-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using protein engineering to understand and modulate aggregation
- (2020) Jessica S Ebo et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Five computational developability guidelines for therapeutic antibody profiling
- (2019) Matthew I. J. Raybould et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Expanded Conformation of an Antibody Fab Region by X-Ray Scattering, Molecular Dynamics, and smFRET Identifies an Aggregation Mechanism
- (2019) Nuria Codina et al. JOURNAL OF MOLECULAR BIOLOGY
- Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubility
- (2019) Aleksander Kuriata et al. NUCLEIC ACIDS RESEARCH
- The role of protein thermodynamics and primary structure in fibrillogenesis of variable domains from immunoglobulin light-chains
- (2019) Enrico Rennella et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Tau local structure shields an amyloid-forming motif and controls aggregation propensity
- (2019) Dailu Chen et al. Nature Communications
- Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
- (2019) Kevin O. Saunders Frontiers in Immunology
- The mutational landscape of a prion-like domain
- (2019) Benedetta Bolognesi et al. Nature Communications
- Continuous directed evolution of proteins with improved soluble expression
- (2018) Tina Wang et al. Nature Chemical Biology
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- Biopharmaceutical benchmarks 2018
- (2018) Gary Walsh NATURE BIOTECHNOLOGY
- An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability
- (2017) M. Jack Borrok et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Biophysical properties of the clinical-stage antibody landscape
- (2017) Tushar Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloidogenesis of Tau protein
- (2017) Bartosz Nizynski et al. PROTEIN SCIENCE
- Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability
- (2017) Mark C. Julian et al. Scientific Reports
- Rapid and accurate in silico solubility screening of a monoclonal antibody library
- (2017) Pietro Sormanni et al. Scientific Reports
- A comparison of biophysical characterization techniques in predicting monoclonal antibody stability
- (2016) Geetha Thiagarajan et al. mAbs
- Understanding and predicting protein misfolding and aggregation: Insights from proteomics
- (2016) Irantzu Pallarès et al. PROTEOMICS
- Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo
- (2016) Claire L. Dobson et al. Scientific Reports
- ANARCI: antigen receptor numbering and receptor classification
- (2015) James Dunbar et al. BIOINFORMATICS
- The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
- (2015) Pietro Sormanni et al. JOURNAL OF MOLECULAR BIOLOGY
- An in vivo platform for identifying inhibitors of protein aggregation
- (2015) Janet C Saunders et al. Nature Chemical Biology
- AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures
- (2015) Rafael Zambrano et al. NUCLEIC ACIDS RESEARCH
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Therapeutic protein aggregation: mechanisms, design, and control
- (2014) Christopher J. Roberts TRENDS IN BIOTECHNOLOGY
- High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy
- (2013) Yuqi Liu et al. mAbs
- Rapid Analysis of Antibody Self-Association in Complex Mixtures Using Immunogold Conjugates
- (2013) Shantanu V. Sule et al. MOLECULAR PHARMACEUTICS
- In vivo detection and quantification of chemicals that enhance protein stability
- (2012) Tsinatkeab T. Hailu et al. ANALYTICAL BIOCHEMISTRY
- Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation
- (2012) Alba Espargaró et al. Molecular BioSystems
- Improved drug-like properties of therapeutic proteins by directed evolution
- (2012) A. Buchanan et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Filtering "genic" open reading frames from genomic DNA samples for advanced annotation
- (2011) Sara D'Angelo et al. BMC GENOMICS
- Linking amyloid protein aggregation and yeast survival
- (2011) Montse Morell et al. Molecular BioSystems
- Recent advances in large-scale production of monoclonal antibodies and related proteins
- (2010) Abhinav A. Shukla et al. TRENDS IN BIOTECHNOLOGY
- Optimizing Protein Stability In Vivo
- (2009) Linda Foit et al. MOLECULAR CELL
- Design of therapeutic proteins with enhanced stability
- (2009) N. Chennamsetty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution
- (2008) Kristoffer Famm et al. JOURNAL OF MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started